Overview

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

Status:
Completed

Trial end date:
2017-05-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to study the combination of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 1.

Phase:

Phase 4

Details

Lead Sponsor:

Federal University of São Paulo

Treatments:

Simeprevir
Sofosbuvir